Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
31.18
-0.68 (-2.13%)
At close: Nov 20, 2025, 4:00 PM EST
31.79
+0.61 (1.96%)
After-hours: Nov 20, 2025, 7:02 PM EST

Ultragenyx Pharmaceutical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-579.83-569.18-606.64-707.42-454.03-186.57
Upgrade
Depreciation & Amortization
35.2935.5426.0118.2213.2412.26
Upgrade
Asset Writedown & Restructuring Costs
---75.03--
Upgrade
Loss (Gain) From Sale of Investments
-5.18-11.51-13.242248.67-169.56
Upgrade
Stock-Based Compensation
155.88158.03135.23130.38104.9585.74
Upgrade
Other Operating Activities
-51-40.99-1.0621.0911.7121.24
Upgrade
Change in Accounts Receivable
-17.81-33.6-22.78-12.07-5.439.84
Upgrade
Change in Inventory
-8.61-11.21-6.93-9.7-3.12-1.35
Upgrade
Change in Accounts Payable
33.3746.990.979.8532.3126.85
Upgrade
Change in Unearned Revenue
-----57.4966.57
Upgrade
Change in Other Net Operating Assets
-7.811.7315.333.8-29.512.75
Upgrade
Operating Cash Flow
-445.67-414.19-474.81-380.47-338.7-132.22
Upgrade
Capital Expenditures
-5.72-7.49-44.27-116.12-73.09-43.91
Upgrade
Cash Acquisitions
----75.03--
Upgrade
Sale (Purchase) of Intangibles
-15-12.5-2.5-30--
Upgrade
Investment in Securities
433.14.66219.82-69.66-121.34-129.66
Upgrade
Other Investing Activities
-1.4-2.44-5.05-0.84-0.94-5.56
Upgrade
Investing Cash Flow
410.98-17.77168-291.65-195.37-179.12
Upgrade
Issuance of Common Stock
86.99392.24388.1710.81119.04600.51
Upgrade
Other Financing Activities
-7-0.03490.4-0.49-0.24
Upgrade
Financing Cash Flow
86.99399.24388.14501.21118.55600.27
Upgrade
Foreign Exchange Rate Adjustments
2.18-2.530.46-1.08-1.191.12
Upgrade
Net Cash Flow
54.49-35.2481.8-171.98-416.71290.05
Upgrade
Free Cash Flow
-451.39-421.68-519.07-496.59-411.79-176.13
Upgrade
Free Cash Flow Margin
-71.58%-75.27%-119.53%-136.68%-117.18%-64.98%
Upgrade
Free Cash Flow Per Share
-4.63-4.66-7.06-7.10-6.07-2.90
Upgrade
Levered Free Cash Flow
-195.18-207.49-312.21-370.58-244.82-86.45
Upgrade
Unlevered Free Cash Flow
-158.89-168.09-270.96-343.7-226.43-65.65
Upgrade
Change in Working Capital
-0.8413.92-15.160.24-63.24104.66
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q